NCCN 2012 Congress Series: Lung Cancers™

Columbus, OH US
May 24, 2012

This congress is a full-day educational program designed to provide an in-depth analysis of the evidence and clinical decision-making that led to the development of the NCCN Guidelines® for Non-Small Cell Lung Cancer and Small Cell Lung Cancer. Participants will learn how to implement the NCCN Guidelines recommendations into their practice and gain a clear understanding of the most up-to-date treatment recommendations for these cancers. As research continues in these areas and new information emerges, it is critical that clinicians are kept up-to-date and informed. This Congress will communicate the NCCN Guidelines in a direct and interactive way to community oncologists and other clinical professionals.

There is a $49 fee for this educational activity for health care providers. There is a $495 fee for industry attendees.

Target Audience

This educational program is designed to meet the educational needs of oncologists, pathologists, nurses, pharmacists, and other health care professionals who manage patients with cancer.

Learning Objectives

Following this congress, participants should be able to:

Non-Small Cell Lung Cancer

  • Describe the appropriate treatment strategies for patients with localized Non-Small Cell Lung Cancer
  • Select the most appropriate therapy for patients with advanced Non-Small Cell Lung Cancer based on specific criteria (e.g., histology)
  • Describe the role of maintenance therapy in Non-Small Cell Lung Cancer
  • Describe newer radiation therapy techniques for patients with Non-Small Cell Lung Cancer (e.g., SBRT, image-guided radiation therapy)

Small Cell Lung Cancer

  • Provide examples of appropriate treatment regimens for patients with extensive stage Small Cell Lung Cancer
  • Discuss the role of surgical therapy in the management of Small Cell Lung Cancer

Palliative Care

  • Summarize the most common and severe symptoms of lung cancer and its treatment that often require palliative care
  • Explain some of the palliative therapies for the most common and severe lung cancer symptoms, such as dyspnea, airway obstruction, and hemoptysis
Additional information
Supporters: 

Supported by an educational donation provided by Amgen. This activity is supported by educational grants from Astellas, Celgene Corporation, Genentech, Lilly USA, LLC, and Pfizer.

Course summary
Available credit: 
  • 5.50 Participation
  • 5.50 Nurse
  • 5.50 Pharmacist
  • 5.50 Physician
Course opens: 
05/24/2012
Course expires: 
10/11/2012
Event starts: 
05/24/2012 - 8:00am
Event ends: 
05/24/2012 - 3:30pm
Cost:
$0.00
The Blackwell Inn and Conference Center
2110 Tuttle Park Place
Columbus, OH 43210
United States

Agenda

7:15 – 8:00 AM
Registration

8:00 – 8:10 AM  

Welcome
Gregory A. Otterson, MD
The Ohio State University Comprehensive Cancer Center -
James Cancer Hospital and Solove Research Institute


NON-SMALL CELL LUNG CANCER

8:10 – 8:55 AM
Surgical Issues in Local Disease
Andrew C. Chang, MD
University of Michigan Comprehensive Cancer Center

9:00 – 9:45 AM
Adjuvant Therapy of Non-Small Cell Lung Cancer
Gregory A. Otterson, MD
The Ohio State University Comprehensive Cancer Center -
James Cancer Hospital and Solove Research Institute


9:45 – 10:05 AM
Break

10:05 – 10:50 AM
Use of Radiation Therapy in Non-Small Cell Lung Cancer
Billy W. Loo, Jr., MD, PhD
Stanford Cancer Institute

10:55 – 11:40 AM
Metastatic Disease of Non-Small Cell Lung Cancer
Renato Martins, MD, MPH
Seattle Cancer Care Alliance

11:40 AM – 12:40 PM
Lunch

SMALL CELL LUNG CANCER

12:40 – 1:40 PM
Management of Extensive-Stage Disease
Gregory P. Kalemkerian, MD
University of Michigan Comprehensive Cancer Center

1:45 – 2:30 PM
Surgical Issues in Small Cell Lung Cancer
Robert J. Downey, MD
Memorial Sloan-Kettering Cancer Center

PALLIATIVE CARE
 

2:35 – 3:20 PM
Palliative Care in Lung Cancer
Michael H. Levy, MD, PhD
Fox Chase Cancer Center

3:20 – 3:30 PM
Closing Remarks

Speakers subject to change based on availability.
 

 

Available Credit

  • 5.50 Participation
  • 5.50 Nurse
  • 5.50 Pharmacist
  • 5.50 Physician

Accreditation Period

Course opens: 
05/24/2012
Course expires: 
10/11/2012

Price

Cost:
$0.00
Please login or register to take this course.